Doctors for America

05/19/2026

We are thrilled to have Stella A. Safo, MD MPH as a featured speaker at our upcoming conference!

Dr. Safo is a Harvard-trained, board-certified HIV primary care physician — and so much more. She is an innovator in healthcare delivery, a passionate advocate for gender and racial equity, and a national voice for systemic change in medicine.

Her impact speaks for itself:

• Founding member of Equity Now at Mount Sinai, VoteHealth 2020, and the Coalition to Advance Antiracism in Medicine

• Named one of Modern Healthcare's Top Minority Clinicians to Watch (2020)

• Co-filed a landmark federal lawsuit against gender, age, and race discrimination in medicine — activism that directly led to the NYC Council creating a Gender and Racial Equity Advisory Committee in 2021

• Ongoing advocate for antiracist federal policy through the Coalition to Advance Antiracism in Medicine

Dr. Safo's story is one of courage, conviction, and collective action. We can't wait for our community to hear from her.

📅 DFA's National Leadership Conference | June 5–8 | Washington, DC

🔗 Register now: https://www.doctorsforamerica.org/national-leadership-conference

05/18/2026

Join the UCLA Law Center on Reproductive Health, Law, & Policy for an expert-led analysis of how these legislative measures safeguard both reproductive rights and access to gender-affirming care.

📅Thursday, May 21
🕗8:00 - 9:00 pm ET

https://ow.ly/uVc950Z1cck

05/13/2026

Get ready to laugh your way into our National Leadership Conference with a special comedy set by the one and only Rab Razzak, MD FAAHPM!

The comedy set is included in the Friday night mixer along with a taco bar, ice cream sundaes, and a powerful storytelling session. All for just $50!

📅 Friday, June 5
🎉 FDA Pre-Conference
📍Washington Plaza Hotel

A full night of laughs, good food, and great company!

Grab your ticket now!
https://www.doctorsforamerica.org/national-leadership-conference-registration

05/13/2026

DFA’s FDA Task Force Concerned by FDA Approval of Flavored Vapes

This week’s announcement that FDA will reverse course and allow the sale of fruit-flavored vapes is another alarming example of political pressure influencing the regulatory process.

https://www.doctorsforamerica.org/news/statement-release-doctors-for-americas-fda-task-force-concerned-by-fda-approval-of-flavored-vapes

05/12/2026

DFA's FDA Task Force is deeply concerned about reports that FDA halted publication of federally funded studies which demonstrated the safety of vaccines for COVID-19 and prevented data from studies on the shingles vaccine from being presented at a major medical meeting.

https://www.doctorsforamerica.org/news/statement-release-doctors-for-americas-fda-task-force-alarmed-by-fda-decision-to-withdraw-vaccine-studies

05/08/2026

From shaping national policy to mobilizing local change, our members continue to put patients over politics.

Together, we are proving that when physicians speak with one voice, the system listens.

Be the voice patients deserve
https://www.doctorsforamerica.org/become-member

05/07/2026

The Reproductive Health Coalition (RHC) reaffirms the safety of mifepristone and supports the administrative stay pausing the 5th Circuit’s ruling in Louisiana v FDA for one week.

“Over 7.5 million U.S. patients have safely used telehealth for abortion care.” says Sophia Yen, MD, MPH

Full statement:
https://www.doctorsforamerica.org/news/statement-release-reproductive-health-coalition-on-mifepristone-access

05/06/2026

Join former Congressman Rob Andrews for a discussion on how evolving federal healthcare policy, particularly the Affordable Care Act, may impact care delivery, cost, and access, alongside ongoing concerns about affordability.

https://ow.ly/oNaj50YV6U5

05/05/2026

Courts Again Disregard Clinical Evidence, Science, and Regulatory Authority to Restrict Access to Mifepristone

Physicians working at the intersection of policy and patient care have emphasized the harm caused by ongoing legal instability. As Dr. Anita Somani, OBGYN and Ohio State Representative, notes, “The ping pong effect of court decisions only impacts our patients and physicians negatively. It is extremely difficult to provide care in a changing legal environment. It will hurt patients at the time when they are most vulnerable. Physicians will err on the side of caution if they are worried about their medical liability and this will impact the patient’s ability to get timely care. There should be a limit to how many times something can be litigated in court.”

Full statement:
https://www.doctorsforamerica.org/news/statement-release-courts-again-disregard-clinical-evidence-science-and-regulatory-authority-to-restrict-access-to-mifepristone

05/02/2026

We are clinicians, advocates, and changemakers united by the belief that an equitable, evidence-based health system is not only possible - it is necessary.

The DFA National Leadership Conference is where the movement comes together to learn, strategize, and organize. It is where clinicians become advocates, and advocates become leaders.

Come join us from June 5-8 as we gather in Washington, DC to make good trouble!

Learn more:
https://www.doctorsforamerica.org/national-leadership-conference

05/01/2026

Opinion | Michigan must regulate ni****ne pouches before new generation lost to addiction

Dr. Anmol Gupta is an internal medicine and pediatrics resident physician at the University of Michigan. He is also a Copello Fellow with Doctors for America.

Ni****ne has serious long-term consequences to the developing brain and body. Michigan needs to act on two fronts. First, move pouches behind the pharmacy counter. Second, close the online sales loophole.